Pharmaceutical industry focuses on Spread of COVID-19 again

Companies highly recommend self-examination

Pharmaceutical companies are also nervous again as the spread of COVID-19 from Itaewon Club in Seoul.

 

Pharmaceutical companies seem to be cautious about unexpected situations when they tried to earnestly engage in sales marketing activities with the government's distancing in daily life.

 

According to the industry on the 13th, a domestic pharmaceutical company e-mailed to all employees to inform the personnel team that they have visited a entertainment area in Itaewon, Seoul, and Gyeonggi Province, or immediately contact a personnel team after the visit to the entertainment district, individuals with personal health problems were notified immediately to contact the human resources team.

 

Most companies recommend self-isolation for 2 weeks after self-examination to employees who have visited Itaewon entertainment store or suspected of symptoms related to corona19 such as fever, cough, sore throat.

 

Samsung Bioepis asked to check the visit to Itaewon through a mobile interview last weekend.

 

During this period, employees who visited nearby Itaewon also made strong preventive measures, such as recommending self-examination.

 

Korean corporations of some multinational pharmaceutical companies such as AstraZeneca Korea and Janssen Korea plan to continue working for a long time with flexible operation of autonomous hours, such as every other day.

 

Panoramic view of an office building lobby in Jung-gu, Seoul with a lot of floating

Pharmaceutical companies are keen on the further spread of COVID-19 by employees who recently visited the Itaewon Club.

 

If the spread of COVID-19 was concentrated in Daegu, Gyeongbuk 3 month ago, it is concentrated on young people in the metropolitan areas such as Seoul and Incheon, which intensifies the anxiety in the industry.

 

In the case of COVID-19 confirmed patients in departments with high proportions of young employees, such as production facilities, research institutes, and sales departments, it is fatal to the operation of the company.

 

In particular, in buildings where it is not possible to work from home, such as production facilities and research institutes, pharmaceutical companies become more nervous in that they have to stop operating for a while if there is one confirmed patient.

 

In fact, a bio company that has a production facility in the metropolitan area said that employees who visited the area near Itaewon were suspicious until they received a negative result for COVID-19.

 

The two companies in Seoul Square building where corona19 confirmed patients visited Itaewon were also nervous.

 

MSD Korea and Mundipharma entered emergency telecommuting on the 11th after receiving a notice that Pernod Ricard Korea’s employee was confirmed on the 10th floor of the same building after visiting a local area near Itaewon in Seoul.

 

Both companies seemed to be confused after ending their three-month telecommuting job and trying to approach work normalization.

 

MSD Korea only started working at the office for only two weeks, but decided to switch to telecommuting and watch the trend.

 

On the evening of the 11th, a management meeting decided to extend telecommuting until the 13th, and instructed employees not to stay in the office.

 

Mundipharma also banned working at the office.

 

Although building disinfection has been completed, it maintains a conservative position to set the time for resumption of work while paying close attention to the guidelines of the quarantine authorities.

 

Companies are strengthening their guidelines to refrain from entering enclosed spaces

The Yonsei Severance Building, where Boeringer Ingelheim of Korea resided, suffered a tumult on the news that the employee on the 11th was in close contact with COVID-19 confirmed patient.

 

It turned out that Hyundai Shell Base Oil executive, the resident of the 7th floor of Yonsei Severance Building, ate with COVID-19 confirmed patient last weekend.

 

Some of the companies in the same building immediately noticed the news and immediately left the company to work and urgent telecommuting was conducted for a day on the 12th, and Boeringer Ingelheim, who resided on the 16th floor, continued normal work.

 

Although the close contact employee finally ended in happening after receiving a negative result, Boeringer Ingelheim, which resumed normal work from the 11th, passed the crisis of returning to home work in one day.

 

An official from the pharmaceutical industry said, "The companies that tried to normalize the management after social distance was relieved by distancing in daily life was again in state of emergency and worried because there were a lot of young employees.

 

but it is also not easy to recommend.

 

The greater the psychological anxiety, the more the business disruption will continue.

 

”